Standout Papers

On-target efficacy of a HIF-2α antagonist in preclinical kidney cancer models 2016 2026 2019 2022 324
  1. On-target efficacy of a HIF-2α antagonist in preclinical kidney cancer models (2016)
    Hyejin Cho, Xinlin Du et al. Nature

Immediate Impact

23 by Nobel laureates 31 from Science/Nature 55 standout
Sub-graph 1 of 21

Citing Papers

Automated self-optimization, intensification, and scale-up of photocatalysis in flow
2024 StandoutScience
Photoexcited nitroarenes for the oxidative cleavage of alkenes
2022 StandoutNature
2 intermediate papers

Works of James P. Rizzi being referenced

3-[(1S,2S,3R)-2,3-Difluoro-1-hydroxy-7-methylsulfonylindan-4-yl]oxy-5-fluorobenzonitrile (PT2977), a Hypoxia-Inducible Factor 2α (HIF-2α) Inhibitor for the Treatment of Clear Cell Renal Cell Carcinoma
2019
A novel product from Beckmann rearrangement of erythromycin A 9(E)-oxime
1994

Author Peers

Author Last Decade Papers Cites
James P. Rizzi 876 247 377 20 1.3k
Candy Robinson 879 166 144 30 1.6k
Dilip Amin 501 212 121 25 1.5k
Charles B. Glaser 669 142 151 35 1.6k
Daniele Avanzato 967 129 332 18 1.7k
Roland Neuhaus 718 117 261 35 1.1k
Sonia Lamontagne 521 313 163 22 1.3k
Edward F. Webb 771 278 160 36 1.7k
F. Javier Piedrafita 944 204 163 42 1.5k
John L. Herrmann 573 183 143 34 1.2k
Alain De Pover 1215 136 142 23 1.5k

All Works

Loading papers...

Rankless by CCL
2026